Is the FDA doing anything about Prempro?
October 15, 2004 09:20

The FDA suggested revising the label to include information about current approved uses Prempro. The suggested label states that if Prempro is solely prescribed for vaginal symptoms, health care providers are advised to consider the use of topical vaginal products. The suggested label recommends that if the products are prescribed for osteoporosis, women should be at significant risk for osteoporosis and that non-estrogen treatments should be considered inappropriate.